British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

Br J Dermatol. 2016 Jul;175(1):23-44. doi: 10.1111/bjd.14816.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Alcohol Drinking
  • Biological Products / adverse effects
  • Bone Marrow Diseases / chemically induced
  • Checklist
  • Chemical and Drug Induced Liver Injury / etiology
  • Chickenpox / complications
  • Child
  • Counseling / methods
  • Cyclosporine / adverse effects
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / poisoning
  • Dermatologic Agents / therapeutic use*
  • Drug Administration Routes
  • Drug Administration Schedule
  • Drug Approval
  • Drug Interactions
  • Drug Monitoring / methods
  • Drug Overdose / etiology
  • Evidence-Based Medicine
  • Female
  • HIV Infections / complications
  • Hepatitis, Viral, Human / complications
  • Humans
  • Intraoperative Complications / chemically induced
  • Kidney Diseases / chemically induced
  • Lung Diseases / chemically induced
  • Methotrexate / adverse effects
  • Methotrexate / poisoning
  • Methotrexate / therapeutic use*
  • Nausea / chemically induced
  • Neoplasms / chemically induced
  • Off-Label Use
  • Patient Education as Topic / methods
  • Patient Safety
  • Pregnancy
  • Pregnancy Complications / prevention & control
  • Retinoids / adverse effects
  • Skin Diseases / drug therapy*
  • Tuberculosis / complications
  • Ultraviolet Rays / adverse effects
  • Vaccination / adverse effects

Substances

  • Biological Products
  • Dermatologic Agents
  • Retinoids
  • Cyclosporine
  • Methotrexate